Clover Health (CLOV) | Stock Overview & Key Data
Clover Health Performance Comparison
Stock Range
Today's Range
Low: $2.51
High: $2.65
on August 21, 2025
52 Week Range
Low: $2.12
High: $4.87
on August 8, 2025
on January 24, 2025
All-Time High: $28.85 on June 7, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.3B
EPS
-0.08
P/E Ratio (TTM)
-31.50
Forward P/E
-18.64
P/B Ratio
3.87
PEG Ratio
0.10
Div. Yield
N/A
ROE
-12.59%
Beta
1.920
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
20.86%
Operating Margin
-2.21%
Profit Margin
-2.68%
Returns and Earnings
Return on Assets (TTM)
-4.26%
Return on Equity (TTM)
-12.59%
EBITDA
$-41.1M
Net Income (TTM)
$-42.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$3.19
Quarterly Revenue Growth (YoY)
34.10%
Quarterly Earnings Growth (YoY)
34.07%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Clover Health CLOV | 1.34B Small-cap | 1.56% | -16.08% | -25.85% | -40.68% | -16.61% | -21.86% | -8.42% | -74.98% |
| UnitedHealth UNH | 279.39B Mega-cap | 11.74% | 7.52% | 0.12% | -34.96% | -39.87% | -48.10% | -42.68% | -3.51% |
| CVS Health CVS | 87.01B Large-cap | 7.04% | 15.88% | 15.01% | 12.52% | 61.53% | 21.58% | -28.61% | 13.00% |
| Progyny PGNY | 1.96B Small-cap | 2.57% | 0.83% | 9.16% | -0.30% | 30.46% | 6.10% | -44.49% | -19.10% |
| Cigna CI | 79.24B Large-cap | 3.65% | 2.09% | -5.09% | 0.38% | 9.64% | -14.98% | 5.64% | 66.13% |
| Elevance Health ELV | 70.84B Large-cap | 4.80% | 11.99% | -22.62% | -19.61% | -15.37% | -43.29% | -35.96% | 11.66% |
Ownership & Short Interest
Insider Ownership
3.88%
Institutional Ownership
35.14%
Shares Short
41M
Short Ratio
4.25
Short % of Shares Outstanding
10.08%
Average 10-Day Volume
11M
Average 90-Day Volume
10M
Clover Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Clover Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CLOV's 52-week high and low?
- In the last 52 weeks, Clover Health reached a high of $4.87 (on January 24, 2025) and a low of $2.12 (on August 8, 2025).
- What is the market cap and P/E ratio for CLOV?
- Curious about Clover Health's size and valuation? Its market capitalization stands at 1.34B. When it comes to valuation, the P/E ratio (trailing twelve months) is -31.50, and the forward P/E (looking ahead) is -18.64.
- Does CLOV pay dividends? If so, what's the yield?
- As for dividends, Clover Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Clover Health's main competitors or similar companies to consider before investing?
When looking at Clover Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UnitedHealth
UNH279.39B Healthcare Healthcare Plans -48.10% -42.68% CVS Health
CVS87.01B Healthcare Healthcare Plans 21.58% -28.61% Progyny
PGNY1.96B Healthcare Healthcare Plans 6.10% -44.49% Cigna
CI79.24B Healthcare Healthcare Plans -14.98% 5.64% Elevance Health
ELV70.84B Healthcare Healthcare Plans -43.29% -35.96% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Clover Health Investments Corp.? (e.g., ROE, Debt/Equity)
- To get a sense of Clover Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -12.59%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 20.86%.
- What is the recent revenue and earnings growth for CLOV?
- Looking at Clover Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 34.10%, and quarterly earnings saw a YoY growth of 34.07%.
- How much of CLOV stock is held by insiders and institutions?
- Wondering who owns Clover Health stock? Company insiders (like executives and directors) hold about 3.88% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 35.14%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.